An Extraordinary Healer essay honoring ROSS FOOTE, OCN [JACK C. MONTGOMERY VA MEDICAL CENTER, MUSKOGEE, OKLAHOMA]
Sarah Sciortino, MSW, LSW, Oncology Psychosocial Support Services Program Coordinator at University of Chicago Hospital, discusses the unique concerns that younger patients with ovarian cancer can face.
This sidebar to the feature “Cancer for the long haul” written by Wendy Harpham, MD, discusses her recurring non-Hodgkin’s lymphoma.
When I learned that lung cancer is the number one cancer killer in the United States, but one of the lowest funded for research, it made me angry.
Day after day, patients come in to receive chemotherapy treatment, passing rooms with warning signs and hospital staff in protective isolation gear. They want to know they are safe.
Linda R. Duska, gynecologic oncologist, University of Virginia, discusses the Foundation for Women's Cancer.
We spoke with Oeffinger during the 2016 Cancer Survivorship Symposium in mid-January.
Patients with PV tend to be very symptomatic, but Jakafi can help.
One of three finalist essays for the 2008 CURE Extraordinary Healer Award Contest.
“Although more evidence is needed before changing clinical practice, these are highly promising results, suggesting that (Bavencio) could prevent patients with chemo-resistant disease from the severe toxicity of chemotherapy combinations.”
An expert discusses the exciting new developments extending survival in the evolving ovarian cancer treatment space.
New Initiative Aims to Foster Informed Discussions Between Newly Diagnosed Lung Cancer Patients, Caregivers and Their Healthcare Team
I am privileged and honored to nominate Miami Cancer Institute (MCI) pediatric oncology nurse Alicia De Pazos, RN, CPHON, for the 2019 CURE® Extraordinary Healer® Award. Alicia has been a pediatric oncology nurse for over 32 years. In that time, she has held many different positions — all in the pediatric oncology setting.
One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.
The combination of Calquence and Rituxan may also be useful during the COVID-19 pandemic as it decreases infusion times and patient interactions, according to an expert.
Fundraising to fight cancer is flourishing in Second Life, a virtual world where peopl's created characters live an alternative "life"
Over the past few decades, prostate cancer has become better understood and treated more effectively.
After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the face of chronic blood cancers.
Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.
Bonnie Joyce Blankert, caregiver and 2016 MPN Hero, discusses the importance of remaining calm when caregiving for a loved one with MPN who recently had a stem cell transplant.
Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.
Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.
Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses educating patients before they enroll on a clinic trial.